Vaishali Pharma Ltd (VAISHALI) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Vaishali Pharma Ltd on NSE and BSE, with an AI summary of each filing.
Vaishali Pharma Limited has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to consider and approve Other business/Increase in authorised capital/Fund raising.
Intimation · 03 Nov 2026, 2:59 am
Vaishali Pharma to Consider Capital Hike and Fundraising on 5th Nov'26 Vaishali Pharma Limited announced a Board of Directors meeting scheduled for 5th Nov'26. The board will evaluate and approve proposals regarding an increase in the company's authorized share capital, potential fund-raising initiatives, and other related business matters.
To consider Fund Raising and other business matters
Intimation · 03 Nov 2026, 2:58 am
Vaishali Pharma Board to Consider Preferential Issue and Capital Increase Vaishali Pharma scheduled a Board meeting on 5th Nov'26 to evaluate raising funds via a preferential issue of equity shares. The Board will also consider increasing authorized share capital from INR 27.00 Cr (13.50 Cr shares of INR 2 each) to INR 29.00 Cr (14.50 Cr shares of INR 2 each), appointing Rohil Sanjay Desai and Ketur Kishor Shah as Additional Independent Non-Executive Directors, and initiating a postal ballot to seek shareholder approval for these proposals.
Vaishali Pharma Limited has informed the Exchange about General Updates
Others (Uncategorized) · 17 Oct 2026, 9:52 pm
NSE Approves Listing of Vaishali Pharma's Preferential Equity Shares Vaishali Pharma Limited received approval from the National Stock Exchange of India for the listing and trading of 4,537,865 equity shares of face value ₹2 each, allotted on a preferential basis. The shares were admitted to dealings effective 16th Oct'26 under the symbol VAISHALI (Series: EQ). The newly issued securities bear distinctive numbers ranging from 130462131 to 134999995 and remain subject to a statutory lock-in period ending on 30th Apr'27.
Vaishali Pharma Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 24, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 25 Sept 2026, 2:07 am
Vaishali Pharma Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 24, 2026
Annual General Meeting · 25 Sept 2026, 2:05 am
Vaishali Pharma Limited has informed the Exchange about General Updates
Others (Uncategorized) · 04 Sept 2026, 9:24 pm
Vaishali Pharma Receives NSE Listing Approval for 4.54 Million Preferential Shares Vaishali Pharma Ltd. received listing approval from the National Stock Exchange of India (NSE) on 3rd Sep'26 for 45,37,865 equity shares of face value Rs. 2 each allotted on a preferential basis. The shares (distinctive numbers 130462131 to 134999995) will be admitted to dealings on the exchange upon receiving credit confirmation to beneficiary accounts from depositories NSDL and CDSL.
Book Closure for the 19th AGM
Annual General Meeting · 02 Sept 2026, 2:08 am
Vaishali Pharma Limited has informed the Exchange that Record date for the purpose of Meeting is 17-Sep-2026.
Others · 02 Sept 2026, 2:02 am
Vaishali Pharma Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026
Annual General Meeting · 02 Sept 2026, 1:55 am
Vaishali Pharma Limited has informed the Exchange about Resignation of Director/KMP/SMP
Change in Management · 15 Aug 2026, 2:02 am
Vaishali Pharma Limited has informed the Exchange about Resignation of Director/KMP/SMP
Change in Management · 15 Aug 2026, 1:59 am
Vaishali Pharma Limited has informed the Exchange about Resignation of Director/KMP/SMP
Change in Management · 15 Aug 2026, 1:53 am
Vaishali Pharma Limited has informed the Exchange regarding Resignation of Bhaveshkumar Popatlal Upadhyay as Non- Executive Independent Director of the company w.e.f. August 14, 2026.
Change in Management · 15 Aug 2026, 1:37 am
Vaishali Pharma Announces Independent Director Resignation Vaishali Pharma announced the resignation of Mr. Bhaveshkumar Popatlal Upadhyay, a Non-Executive Independent Director, effective from the close of business on 14 Aug'26. The resignation is attributed to personal and professional reasons, as confirmed in his resignation letter. The company has stated there are no other material reasons for his departure and noted that he holds no other directorships in listed entities. This event is a key change in the company's board composition.
Vaishali Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
Financial Result · 14 Aug 2026, 9:25 pm
Vaishali Pharma Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lacs) ■ Revenue: 2,289 (+17.6% YoY | -15.0% QoQ) ■ EBITDA: 149 (+56.8% YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 6.5 (+162 bps YoY | Loss to Profit QoQ) ■ PAT: 155 (+107.4% YoY | +305.8% QoQ) ■ EPS (INR): 0.12 (+100.0% YoY | +300.0% QoQ)
Vaishali Pharma Limited has informed the Exchange about Board Meeting to be held on 14-Aug-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2026 and Other business.
Intimation · 14 Aug 2026, 5:30 am
Vaishali Pharma Board to Approve Q1FY27 Results on 14-Aug'26 Vaishali Pharma has announced a Board of Directors meeting scheduled for 14-Aug'26. The primary agenda is to consider and approve the unaudited financial results for the quarter ending 30-Jun'26. Other business matters will also be discussed.
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
Intimation · 29 Jun 2026, 5:30 am
Vaishali Pharma Board to Approve Q1FY27 Results on 14th Aug'26 Vaishali Pharma Ltd. has scheduled a Board of Directors meeting for 14th Aug'26 to consider and approve the unaudited financial results for the quarter ended 30th Jun'26. The agenda also includes approving the Annual Report for the financial year ended 31st Mar'26. Additionally, the board will finalize the date and notice for the 19th Annual General Meeting and appoint a scrutinizer for remote e-voting.
Vaishali Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on July 08, 2026.
Outcome · 09 Jul 2026, 4:07 pm
Vaishali Pharma Defers Proposal for Preferential Equity Share Issue Vaishali Pharma's Board of Directors, in a meeting on 8th Jul'26, considered a proposal for a preferential issue of equity shares. After deliberations, the Board decided to defer the proposal for further evaluation and consideration. Consequently, no decision was taken on the potential capital raise. The company will provide further updates to the stock exchange as and when the matter is reconsidered and approved.
Vaishali Pharma Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 05 Jul 2026, 1:29 am
Vaishali Pharma Shareholders Approve Board Re-appointments and CFO Remuneration Hike On 04th Jul'26, Vaishali Pharma announced shareholder approval for four special resolutions via postal ballot. These included the re-appointment of Independent Director Pratik Jakhelia, Managing Director Atul Vasani, and Whole-Time Director Jagruti Vasani. Shareholders also approved an increase in remuneration for Director and CFO Dewansh Vasani. All resolutions were passed with overwhelming majorities, receiving over 99.85% of votes in favor, following the postal ballot notice issued on 23rd May'26. Promoters abstained from voting on resolutions where they were an interested party.
Vaishali Pharma Limited has informed the Exchange about General Updates
Others (Uncategorized) · 04 Jul 2026, 1:59 am
Vaishali Pharma Allots 45.38 Lakh Shares to Kesar Pharma On 03rd Jul'26, Vaishali Pharma’s board allotted 45,37,865 equity shares to Kesar Pharma Limited on a preferential basis at an issue price of Rs. 20 per share. This non-cash transaction, valued at Rs. 9.08 crore, was in exchange for a 26.95% stake in Kesar Pharma. Post-allotment, Kesar Pharma holds a 3.36% stake in Vaishali Pharma. The company’s paid-up equity share capital increased to Rs. 26.99 crore, comprising 13,49,99,995 shares of Rs. 2 each.
Vaishali Pharma Limited has informed the Exchange regarding allotment of 4537865 securities pursuant to Preferential Issue at its meeting held on July 03, 2026
Others (Uncategorized) · 04 Jul 2026, 1:57 am
Vaishali Pharma Allots 4.54 mn Shares to Kesar Pharma via Preferential Issue Vaishali Pharma's board approved the preferential allotment of 45,37,865 equity shares to Kesar Pharma Limited on 03rd Jul'26. The shares, with a face value of Rs. 2 each, were issued at Rs. 20 per share (including an Rs. 18 premium), aggregating to Rs. 9.08 Cr. This non-cash transaction was made in consideration for acquiring a 26.95% stake in Kesar Pharma. Post-allotment, Vaishali Pharma's paid-up capital increased to Rs. 27.00 Cr, and Kesar Pharma will hold a 3.36% stake in the company.
Vaishali Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on July 02, 2026.
Outcome · 03 Jul 2026, 2:00 am
Vaishali Pharma to Increase Authorised Capital, Defers Share Allotment On 2nd Jul'26, Vaishali Pharma's board approved increasing its authorised share capital from INR 27 crore to INR 29 crore, subject to member approval via postal ballot. This changes the share structure from 13.50 crore to 14.50 crore equity shares of Rs. 2 each. The board also deferred a proposal for the issue and allotment of 61,23,000 equity shares.